These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33523669)

  • 1. Computational Assessment of Combination Therapy of Androgen Receptor-Targeting Compounds.
    Fischer A; Häuptli F; Lill MA; Smieško M
    J Chem Inf Model; 2021 Feb; 61(2):1001-1009. PubMed ID: 33523669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Dynamics Simulations Revealed the Regulation of Ligands to the Interactions between Androgen Receptor and Its Coactivator.
    Liu N; Zhou W; Guo Y; Wang J; Fu W; Sun H; Li D; Duan M; Hou T
    J Chem Inf Model; 2018 Aug; 58(8):1652-1661. PubMed ID: 29993249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric conversation in the androgen receptor ligand-binding domain surfaces.
    Grosdidier S; Carbó LR; Buzón V; Brooke G; Nguyen P; Baxter JD; Bevan C; Webb P; Estébanez-Perpiñá E; Fernández-Recio J
    Mol Endocrinol; 2012 Jul; 26(7):1078-90. PubMed ID: 22653923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Dynamics of Agonist and Antagonist Binding to the Androgen Receptor.
    Azhagiya Singam ER; Tachachartvanich P; La Merrill MA; Smith MT; Durkin KA
    J Phys Chem B; 2019 Sep; 123(36):7657-7666. PubMed ID: 31431014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells.
    Dehm SM; Tindall DJ
    J Biol Chem; 2006 Sep; 281(38):27882-93. PubMed ID: 16870607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor modulators: a review of recent patents and reports (2012-2018).
    Fujii S; Kagechika H
    Expert Opin Ther Pat; 2019 Jun; 29(6):439-453. PubMed ID: 31092069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide antagonist of the androgen receptor.
    Gao W
    Curr Pharm Des; 2010; 16(9):1106-13. PubMed ID: 20030610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Learning from estrogen receptor antagonism: structure-based identification of novel antiandrogens effective against multiple clinically relevant androgen receptor mutants.
    Liu B; Geng G; Lin R; Ren C; Wu JH
    Chem Biol Drug Des; 2012 Mar; 79(3):300-12. PubMed ID: 22151347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic Insights into the Allosteric Inhibition of Androgen Receptors by Binding Function 3 Antagonists from an Integrated Molecular Modeling Study.
    Kong X; Xing E; Zhuang T; Li PK; Cheng X
    J Chem Inf Model; 2021 Jul; 61(7):3477-3494. PubMed ID: 34165949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel androgen receptor antagonists using structure- and ligand-based methods.
    Li H; Ren X; Leblanc E; Frewin K; Rennie PS; Cherkasov A
    J Chem Inf Model; 2013 Jan; 53(1):123-30. PubMed ID: 23278403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Diversity of Ligand-Binding Androgen Receptors Revealed by Microsecond Long Molecular Dynamics Simulations and Enhanced Sampling.
    Duan M; Liu N; Zhou W; Li D; Yang M; Hou T
    J Chem Theory Comput; 2016 Sep; 12(9):4611-9. PubMed ID: 27560203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling androgen receptor flexibility: a binding mode hypothesis of CYP17 inhibitors/antiandrogens for prostate cancer therapy.
    Gianti E; Zauhar RJ
    J Chem Inf Model; 2012 Oct; 52(10):2670-83. PubMed ID: 22924551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assays to Interrogate the Ability of Compounds to Inhibit the AF-2 or AF-1 Transactivation Domains of the Androgen Receptor.
    Fancher AT; Hua Y; Strock CJ; Johnston PA
    Assay Drug Dev Technol; 2019; 17(8):364-386. PubMed ID: 31502857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine Disruption at the Androgen Receptor: Employing Molecular Dynamics and Docking for Improved Virtual Screening and Toxicity Prediction.
    Wahl J; Smieško M
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Targeted Bivalent Androgen Receptor Binding Compound for Prostate Cancer Therapy.
    Chowdhury S; Beitel LK; Lumbroso R; Purisima EO; Paliouras M; Trifiro M
    Horm Cancer; 2019 Feb; 10(1):24-35. PubMed ID: 30565014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain.
    Banuelos CA; Tavakoli I; Tien AH; Caley DP; Mawji NR; Li Z; Wang J; Yang YC; Imamura Y; Yan L; Wen JG; Andersen RJ; Sadar MD
    J Biol Chem; 2016 Oct; 291(42):22231-22243. PubMed ID: 27576691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A surface on the androgen receptor that allosterically regulates coactivator binding.
    Estébanez-Perpiñá E; Arnold LA; Nguyen P; Rodrigues ED; Mar E; Bateman R; Pallai P; Shokat KM; Baxter JD; Guy RK; Webb P; Fletterick RJ
    Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16074-9. PubMed ID: 17911242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiandrogens in prostate cancer.
    Reid P; Kantoff P; Oh W
    Invest New Drugs; 1999; 17(3):271-84. PubMed ID: 10665479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Novel Androgen Receptor Ligands by Structure-based Virtual Screening and Bioassays.
    Zhou W; Duan M; Fu W; Pang J; Tang Q; Sun H; Xu L; Chang S; Li D; Hou T
    Genomics Proteomics Bioinformatics; 2018 Dec; 16(6):416-427. PubMed ID: 30639122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and Activation.
    Lallous N; Leblanc E; Munuganti RS; Hassona MD; Nakouzi NA; Awrey S; Morin H; Roshan-Moniri M; Singh K; Lawn S; Yamazaki T; Adomat HH; Andre C; Daugaard M; Young RN; Guns ES; Rennie PS; Cherkasov A
    Mol Cancer Ther; 2016 Dec; 15(12):2936-2945. PubMed ID: 27765852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.